A Nicotine Pouch Looks Like Nothing in Someone's Lip. That's the Whole Design Problem.
Teen use of pouches like Zyn nearly quadrupled between 2022 and 2025. The reason isn't flavor — it's that a product with no smoke, no vapor, and no smell is built to disappear from every adult who might notice.
Nicotine pouch use among teens nearly quadrupled between 2022 and 2025, and the FDA’s own National Youth Tobacco Survey shows current use jumping from 3.0% to 5.4% of teens in a single year, 2023 to 2024. More than one in six of those kids said they use pouches daily. This is happening seven months after the FDA authorized 20 Zyn products to carry a “modified risk” label — technically true relative to cigarettes, and irrelevant to a 15-year-old whose brain isn’t finished developing and who was never going to smoke a cigarette in the first place.
A pouch tucked in someone’s lip produces no smoke, no vapor, and no smell — which means it produces no adult intervention either, and that silence is doing more to drive this surge than any flavor on the market.
Nicotine before age 25 disrupts the brain circuitry handling attention, mood regulation, and impulse control — not as a vague long-term risk, but as a documented developmental effect tied to how young a nervous system still is while it’s absorbing regular nicotine exposure. What makes pouches different from the vape generation before them isn’t the chemistry. It’s the psychology of concealment. A vape cloud gets noticed in a bathroom, a car, a bedroom. A pouch sits under the lip through an entire class period, an entire car ride home, an entire dinner, visible to no one who isn’t looking directly for it. For a teenager already inclined to self-medicate anxiety, boredom, or social pressure, that invisibility isn’t a side effect of the product — for some teens, it is the product’s main appeal, letting them manage a feeling without ever having a conversation about why they needed to.
That’s the piece worth sitting with if you’re a parent, a school counselor, or a case manager working with adolescents: the discretion that makes a pouch marketable to adults trying to quit smoking is the identical feature that makes early dependence in a teenager nearly undetectable until the habit is already established. There’s no smell to catch, no residue to find, no obvious behavioral tell — just a kid who’s quietly built a relationship with nicotine that started before anyone in the room knew to ask the question. Asking early, even without visible evidence, is the only intervention this particular design flaw leaves available.
Sources Cited
- 01.BNicotine Pouch Use Surges Among Young PeopleCDC Foundation
- 02.A
Filed Under
psychologytreatment
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
One-Third of Methadone Clinics Still Choose Punishment Over Treatment
A STAT News survey of 241 clinics shows most opioid treatment programs dropped medication-as-punishment after SAMHSA's 2024 overhaul — and Pew data shows take-home doses haven't increased diversion. So what are the holdouts still protecting?
Treatment & RecoveryMeth and Cocaine Still Have No Approved Medication — and the One Treatment That Works Is Starving for Funding
There's no FDA-approved medication for methamphetamine or cocaine use disorder. Contingency management is the only treatment with strong evidence behind it — and it's chronically underfunded, politically fragile, and stigmatized as 'paying people not to use drugs.'
Treatment & RecoveryA Hospital Sent Jean Descamps to a Bus Stop Instead of Treatment. He Died Hours Later.
Jean Descamps died hours after a Portland-area hospital discharged him with naloxone but no addiction treatment. NPR's investigation, new Yale craving research, and a Stat News insurance story show the failure is stigma, not evidence.